Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia

Intensive antiplatelet therapy did not reduce recurrent stroke/transient ischaemic attack (TIA) events as compared with guideline treatment in the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial, but did increase the frequency and severity of bleeding. In this pre-...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodhouse, Lisa J., Appleton, Jason P., Christensen, Hanne, Dineen, Rob A., England, Timothy J., James, Marilyn, Krishnan, Kailash, Montgomery, Alan A., Ranta, Anna, Robinson, Thompson G., Sprigg, Nikola, Bath, Philip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359249/
https://www.ncbi.nlm.nih.gov/pubmed/37474599
http://dx.doi.org/10.1038/s41598-023-38474-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359249/
https://www.ncbi.nlm.nih.gov/pubmed/37474599
http://dx.doi.org/10.1038/s41598-023-38474-2

Ejemplares similares